Global and Japan Companion Diagnostics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Immunohistochemistry (IHC)
1.2.4 In Situ Hybridization (ISH)
1.2.5 Next Generation Sequencing (NGS)
1.3 Market by Application
1.3.1 Global Companion Diagnostics Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Pharmaceutical Companies
1.3.4 Laboratories
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostics Market Perspective (2015-2026)
2.2 Global Companion Diagnostics Growth Trends by Regions
2.2.1 Companion Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Companion Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Companion Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostics Players by Market Size
3.1.1 Global Top Companion Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Companion Diagnostics Revenue Market Share by Players (2015-2020)
3.2 Global Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostics Revenue
3.4 Global Companion Diagnostics Market Concentration Ratio
3.4.1 Global Companion Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostics Revenue in 2019
3.5 Key Players Companion Diagnostics Area Served
3.6 Key Players Companion Diagnostics Product Solution and Service
3.7 Date of Enter into Companion Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostics Breakdown Data by Type (2015-2026)
4.1 Global Companion Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Companion Diagnostics Forecasted Market Size by Type (2021-2026)
5 Companion Diagnostics Breakdown Data by Application (2015-2026)
5.1 Global Companion Diagnostics Historic Market Size by Application (2015-2020)
5.2 Global Companion Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Companion Diagnostics Market Size (2015-2026)
6.2 North America Companion Diagnostics Market Size by Type (2015-2020)
6.3 North America Companion Diagnostics Market Size by Application (2015-2020)
6.4 North America Companion Diagnostics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Companion Diagnostics Market Size (2015-2026)
7.2 Europe Companion Diagnostics Market Size by Type (2015-2020)
7.3 Europe Companion Diagnostics Market Size by Application (2015-2020)
7.4 Europe Companion Diagnostics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Companion Diagnostics Market Size (2015-2026)
8.2 China Companion Diagnostics Market Size by Type (2015-2020)
8.3 China Companion Diagnostics Market Size by Application (2015-2020)
8.4 China Companion Diagnostics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Companion Diagnostics Market Size (2015-2026)
9.2 Japan Companion Diagnostics Market Size by Type (2015-2020)
9.3 Japan Companion Diagnostics Market Size by Application (2015-2020)
9.4 Japan Companion Diagnostics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Companion Diagnostics Market Size (2015-2026)
10.2 Southeast Asia Companion Diagnostics Market Size by Type (2015-2020)
10.3 Southeast Asia Companion Diagnostics Market Size by Application (2015-2020)
10.4 Southeast Asia Companion Diagnostics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Roche Holdings
11.1.1 Roche Holdings Company Details
11.1.2 Roche Holdings Business Overview
11.1.3 Roche Holdings Companion Diagnostics Introduction
11.1.4 Roche Holdings Revenue in Companion Diagnostics Business (2015-2020))
11.1.5 Roche Holdings Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Companion Diagnostics Introduction
11.2.4 Abbott Laboratories Revenue in Companion Diagnostics Business (2015-2020)
11.2.5 Abbott Laboratories Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Companion Diagnostics Introduction
11.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostics Business (2015-2020)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Companion Diagnostics Introduction
11.4.4 Agilent Technologies Revenue in Companion Diagnostics Business (2015-2020)
11.4.5 Agilent Technologies Recent Development
11.5 Life Technologies
11.5.1 Life Technologies Company Details
11.5.2 Life Technologies Business Overview
11.5.3 Life Technologies Companion Diagnostics Introduction
11.5.4 Life Technologies Revenue in Companion Diagnostics Business (2015-2020)
11.5.5 Life Technologies Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Companion Diagnostics Introduction
11.6.4 GE Healthcare Revenue in Companion Diagnostics Business (2015-2020)
11.6.5 GE Healthcare Recent Development
11.7 Agendia
11.7.1 Agendia Company Details
11.7.2 Agendia Business Overview
11.7.3 Agendia Companion Diagnostics Introduction
11.7.4 Agendia Revenue in Companion Diagnostics Business (2015-2020)
11.7.5 Agendia Recent Development
11.8 Qiagen
11.8.1 Qiagen Company Details
11.8.2 Qiagen Business Overview
11.8.3 Qiagen Companion Diagnostics Introduction
11.8.4 Qiagen Revenue in Companion Diagnostics Business (2015-2020)
11.8.5 Qiagen Recent Development
11.9 Genomic Health
11.9.1 Genomic Health Company Details
11.9.2 Genomic Health Business Overview
11.9.3 Genomic Health Companion Diagnostics Introduction
11.9.4 Genomic Health Revenue in Companion Diagnostics Business (2015-2020)
11.9.5 Genomic Health Recent Development
11.10 Myriad Genetics
11.10.1 Myriad Genetics Company Details
11.10.2 Myriad Genetics Business Overview
11.10.3 Myriad Genetics Companion Diagnostics Introduction
11.10.4 Myriad Genetics Revenue in Companion Diagnostics Business (2015-2020)
11.10.5 Myriad Genetics Recent Development
11.11 Advanced Cell Diagnostics
10.11.1 Advanced Cell Diagnostics Company Details
10.11.2 Advanced Cell Diagnostics Business Overview
10.11.3 Advanced Cell Diagnostics Companion Diagnostics Introduction
10.11.4 Advanced Cell Diagnostics Revenue in Companion Diagnostics Business (2015-2020)
10.11.5 Advanced Cell Diagnostics Recent Development
11.12 Danaher
10.12.1 Danaher Company Details
10.12.2 Danaher Business Overview
10.12.3 Danaher Companion Diagnostics Introduction
10.12.4 Danaher Revenue in Companion Diagnostics Business (2015-2020)
10.12.5 Danaher Recent Development
11.13 Applied Proteomics
10.13.1 Applied Proteomics Company Details
10.13.2 Applied Proteomics Business Overview
10.13.3 Applied Proteomics Companion Diagnostics Introduction
10.13.4 Applied Proteomics Revenue in Companion Diagnostics Business (2015-2020)
10.13.5 Applied Proteomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Companion Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Polymerase Chain Reaction (PCR)
Table 4. Key Players of Immunohistochemistry (IHC)
Table 5. Key Players of In Situ Hybridization (ISH)
Table 6. Key Players of Next Generation Sequencing (NGS)
Table 7. Global Companion Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Companion Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Companion Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Companion Diagnostics Market Share by Regions (2015-2020)
Table 11. Global Companion Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Companion Diagnostics Market Share by Regions (2021-2026)
Table 13. Companion Diagnostics Market Market Trends
Table 14. Companion Diagnostics Market Drivers
Table 15. Companion Diagnostics Market Challenges
Table 16. Companion Diagnostics Market Restraints
Table 17. Global Companion Diagnostics Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Companion Diagnostics Market Share by Players (2015-2020)
Table 19. Global Top Companion Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostics as of 2019)
Table 20. Global Companion Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Companion Diagnostics Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Companion Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Companion Diagnostics Market Size Share by Type (2015-2020)
Table 26. Global Companion Diagnostics Revenue Market Share by Type (2021-2026)
Table 27. Global Companion Diagnostics Market Size Share by Application (2015-2020)
Table 28. Global Companion Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Companion Diagnostics Market Size Share by Application (2021-2026)
Table 30. North America Companion Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Companion Diagnostics Market Share by Type (2015-2020)
Table 32. North America Companion Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Companion Diagnostics Market Share by Application (2015-2020)
Table 34. North America Companion Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Companion Diagnostics Market Share by Country (2015-2020)
Table 36. Europe Companion Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Companion Diagnostics Market Share by Type (2015-2020)
Table 38. Europe Companion Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Companion Diagnostics Market Share by Application (2015-2020)
Table 40. Europe Companion Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Companion Diagnostics Market Share by Country (2015-2020)
Table 42. China Companion Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 43. China Companion Diagnostics Market Share by Type (2015-2020)
Table 44. China Companion Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 45. China Companion Diagnostics Market Share by Application (2015-2020)
Table 46. China Companion Diagnostics Market Size by Region (US$ Million) (2015-2020)
Table 47. China Companion Diagnostics Market Share by Region (2015-2020)
Table 48. Japan Companion Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Companion Diagnostics Market Share by Type (2015-2020)
Table 50. Japan Companion Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Companion Diagnostics Market Share by Application (2015-2020)
Table 52. Japan Companion Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Companion Diagnostics Market Share by Country (2015-2020)
Table 54. Southeast Asia Companion Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Companion Diagnostics Market Share by Type (2015-2020)
Table 56. Southeast Asia Companion Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Companion Diagnostics Market Share by Application (2015-2020)
Table 58. Southeast Asia Companion Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Companion Diagnostics Market Share by Country (2015-2020)
Table 60. Roche Holdings Company Details
Table 61. Roche Holdings Business Overview
Table 62. Roche Holdings Product
Table 63. Roche Holdings Revenue in Companion Diagnostics Business (2015-2020) (US$ Million)
Table 64. Roche Holdings Recent Development
Table 65. Abbott Laboratories Company Details
Table 66. Abbott Laboratories Business Overview
Table 67. Abbott Laboratories Product
Table 68. Abbott Laboratories Revenue in Companion Diagnostics Business (2015-2020) (US$ Million)
Table 69. Abbott Laboratories Recent Development
Table 70. Thermo Fisher Scientific Company Details
Table 71. Thermo Fisher Scientific Business Overview
Table 72. Thermo Fisher Scientific Product
Table 73. Thermo Fisher Scientific Revenue in Companion Diagnostics Business (2015-2020) (US$ Million)
Table 74. Thermo Fisher Scientific Recent Development
Table 75. Agilent Technologies Company Details
Table 76. Agilent Technologies Business Overview
Table 77. Agilent Technologies Product
Table 78. Agilent Technologies Revenue in Companion Diagnostics Business (2015-2020) (US$ Million)
Table 79. Agilent Technologies Recent Development
Table 80. Life Technologies Company Details
Table 81. Life Technologies Business Overview
Table 82. Life Technologies Product
Table 83. Life Technologies Revenue in Companion Diagnostics Business (2015-2020) (US$ Million)
Table 84. Life Technologies Recent Development
Table 85. GE Healthcare Company Details
Table 86. GE Healthcare Business Overview
Table 87. GE Healthcare Product
Table 88. GE Healthcare Revenue in Companion Diagnostics Business (2015-2020) (US$ Million)
Table 89. GE Healthcare Recent Development
Table 90. Agendia Company Details
Table 91. Agendia Business Overview
Table 92. Agendia Product
Table 93. Agendia Revenue in Companion Diagnostics Business (2015-2020) (US$ Million)
Table 94. Agendia Recent Development
Table 95. Qiagen Business Overview
Table 96. Qiagen Product
Table 97. Qiagen Company Details
Table 98. Qiagen Revenue in Companion Diagnostics Business (2015-2020) (US$ Million)
Table 99. Qiagen Recent Development
Table 100. Genomic Health Company Details
Table 101. Genomic Health Business Overview
Table 102. Genomic Health Product
Table 103. Genomic Health Revenue in Companion Diagnostics Business (2015-2020) (US$ Million)
Table 104. Genomic Health Recent Development
Table 105. Myriad Genetics Company Details
Table 106. Myriad Genetics Business Overview
Table 107. Myriad Genetics Product
Table 108. Myriad Genetics Revenue in Companion Diagnostics Business (2015-2020) (US$ Million)
Table 109. Myriad Genetics Recent Development
Table 110. Advanced Cell Diagnostics Company Details
Table 111. Advanced Cell Diagnostics Business Overview
Table 112. Advanced Cell Diagnostics Product
Table 113. Advanced Cell Diagnostics Revenue in Companion Diagnostics Business (2015-2020) (US$ Million)
Table 114. Advanced Cell Diagnostics Recent Development
Table 115. Danaher Company Details
Table 116. Danaher Business Overview
Table 117. Danaher Product
Table 118. Danaher Revenue in Companion Diagnostics Business (2015-2020) (US$ Million)
Table 119. Danaher Recent Development
Table 120. Applied Proteomics Company Details
Table 121. Applied Proteomics Business Overview
Table 122. Applied Proteomics Product
Table 123. Applied Proteomics Revenue in Companion Diagnostics Business (2015-2020) (US$ Million)
Table 124. Applied Proteomics Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Companion Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Immunohistochemistry (IHC) Features
Figure 4. In Situ Hybridization (ISH) Features
Figure 5. Next Generation Sequencing (NGS) Features
Figure 6. Global Companion Diagnostics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Laboratories Case Studies
Figure 10. Other Case Studies
Figure 11. Companion Diagnostics Report Years Considered
Figure 12. Global Companion Diagnostics Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Companion Diagnostics Market Share by Regions: 2020 VS 2026
Figure 14. Global Companion Diagnostics Market Share by Regions (2021-2026)
Figure 15. Global Companion Diagnostics Market Share by Players in 2019
Figure 16. Global Top Companion Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Companion Diagnostics Revenue in 2019
Figure 18. North America Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Middle East & Africa Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Roche Holdings Revenue Growth Rate in Companion Diagnostics Business (2015-2020)
Figure 46. Abbott Laboratories Revenue Growth Rate in Companion Diagnostics Business (2015-2020)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostics Business (2015-2020)
Figure 48. Agilent Technologies Revenue Growth Rate in Companion Diagnostics Business (2015-2020)
Figure 49. Life Technologies Revenue Growth Rate in Companion Diagnostics Business (2015-2020)
Figure 50. GE Healthcare Revenue Growth Rate in Companion Diagnostics Business (2015-2020)
Figure 51. Agendia Revenue Growth Rate in Companion Diagnostics Business (2015-2020)
Figure 52. Qiagen Revenue Growth Rate in Companion Diagnostics Business (2015-2020)
Figure 53. Genomic Health Revenue Growth Rate in Companion Diagnostics Business (2015-2020)
Figure 54. Myriad Genetics Revenue Growth Rate in Companion Diagnostics Business (2015-2020)
Figure 55. Advanced Cell Diagnostics Revenue Growth Rate in Companion Diagnostics Business (2015-2020)
Figure 56. Danaher Revenue Growth Rate in Companion Diagnostics Business (2015-2020)
Figure 57. Applied Proteomics Revenue Growth Rate in Companion Diagnostics Business (2015-2020)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed